Abstract
In this issue of Blood, Poe et al identify the pathogenic and druggable B-cell receptor (BCR)–Notch axis as a feed-forward loop in patients with chronic graft-versus-host disease (cGVHD), providing a rationale and methods for its therapeutic targeting.1
Cite
CITATION STYLE
APA
Radojcic, V., & Luznik, L. (2017, November 9). Notching up B-cell pathology in chronic GVHD. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-09-805366
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free